BIB Among An Index ETFs
End-of-day Nov 18, 2026 · 50 An index ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.3% | −12.0% | −4.9% | −8.8% | +36.0% | +41.6% | +166.1% | +29.6% | +183.8% | +1,386.7% |
| Peer average | −1.4% | −16.8% | −25.0% | −32.9% | −15.3% | −12.4% | +72.7% | +28.2% | +272.2% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$176 of every $1,000 in BIB is Proshares
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | IQMMProshares Genius MNY MKT ETF | Financial Services | 17.59% | $1,758.87 | 170K | $17.0M |
| 2 | —Net Other Assets (Liabilities) | — | 17.25% | $1,725.47 | 16.7M | $16.7M |
| 3 | GILDGilead Sciences | Healthcare | 6.17% | $616.87 | 35K | $6.0M |
| 4 | AMGNAmgen | Healthcare | 5.65% | $564.82 | 12K | $5.5M |
| 5 | VRTXVertex Pharmaceuticals | Healthcare | 5.20% | $520.12 | 9,419 | $5.0M |
| 6 | REGNRegeneron Pharmaceuticals | Healthcare | 4.20% | $420.37 | 4,246 | $4.1M |
| 7 | MRNAModerna | Healthcare | 3.58% | $358.32 | 17K | $3.5M |
| 8 | BIIBBiogen | Healthcare | 1.61% | $160.83 | 6,204 | $1.6M |
| 9 | RVMDRevolution Medicines | Healthcare | 1.51% | $151.34 | 8,999 | $1.5M |
| 10 | ILMNIllumina | Healthcare | 1.33% | $132.78 | 6,340 | $1.3M |
| 11 | RPRXRoyalty Pharma | Healthcare | 1.33% | $132.72 | 19K | $1.3M |
| 12 | ROIVRoivant Sciences | Healthcare | 1.21% | $121.35 | 30K | $1.2M |
| 13 | INSMInsmed | Healthcare | 1.15% | $115.49 | 9,168 | $1.1M |
| 14 | ARGXArgenx SE | Healthcare | 1.12% | $112.25 | 1,146 | $1.1M |
| 15 | UTHRUnited Therapeutics | Healthcare | 1.09% | $108.80 | 1,802 | $1.1M |
of the $116B in 408 An index ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | IQMM | Proshares Genius MNY MKT ETF | 17.59% |
| 2 | GILD | Gilead Sciences | 6.17% |
| 3 | AMGN | Amgen | 5.65% |
| 4 | VRTX | Vertex Pharmaceuticals | 5.20% |
| 5 | REGN | Regeneron Pharmaceuticals | 4.20% |
| 6 | MRNA | Moderna | 3.58% |
| 7 | BIIB | Biogen | 1.61% |
| 8 | RVMD | Revolution Medicines | 1.51% |
| 9 | ILMN | Illumina | 1.33% |
| 10 | RPRX | Royalty Pharma - | 1.33% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.0826 |
| Mar 25, 2026 | Mar 31, 2026 | $0.0071 |
| Dec 24, 2025 | Dec 31, 2025 | $0.13 |
| Sep 24, 2025 | Sep 30, 2025 | $0.18 |
| Jun 25, 2025 | Jul 1, 2025 | $0.17 |
| Mar 26, 2025 | Apr 1, 2025 | $0.13 |
| Dec 23, 2024 | Dec 31, 2024 | $0.40 |
| Sep 25, 2024 | Oct 2, 2024 | $0.15 |
| Jun 26, 2024 | Jul 3, 2024 | $0.26 |
| Mar 20, 2024 | Mar 27, 2024 | $0.0403 |
| Dec 20, 2023 | Dec 28, 2023 | $0.0384 |
| Dec 22, 2022 | Dec 30, 2022 | $0.0199 |